Search for: "Barr Laboratories IncĀ " Results 81 - 100 of 166
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Aug 2009, 10:29 pm
Our office is investigating claims of injury related to the birth control pills known as Yaz or Yasmin:Yasmin and Yaz are two types of birth control pills manufactured by Bayer Healthcare, and the generic, Ocella, is marketed and distributed by Barr Laboratories, Inc. [read post]
22 Jun 2015, 2:12 pm by Tom Lamb
Claimants allege that they have suffered personal injuries, some of them fatal, from the use of Bayer’s drospirenone-containing oral contraceptive products such as Yasmin™ and/or yaz™ or from the use of Ocella™ and/or Gianvi™, generic versions of Yasmin™ and yaz™, respectively, marketed by Barr Laboratories, Inc. in the United States. [read post]
24 Nov 2010, 12:37 am by Kelly
Use of pipeline system (IP tango) EU: Notes from EU Parliament meeting on innovation+access for medical technologies (KEI) Netherlands: District Court of The Hague declares Dutch part of Bayer’s European patent covering anti-TNF alpha human monoclonal antibodies invalid (Kluwer Patent Blog) Southeast Asia: Generic drug market picks up steam in Southeast Asia, finds Front & Sullivan (GenericsWeb) Spain: Commercial Court No 5 of Barcelona: obtaining price for generic medicament an act of… [read post]
14 Jan 2010, 11:08 pm by Dr. Shezad Malik
A dozen companies that sold the drugs are named in the Arkansas suits, including Pfizer Inc. and Wyeth Pharmaceuticals Inc., Barr Laboratories Inc. and Mead Johnson & Co., among others. [read post]
30 Jul 2013, 2:58 pm by Todd Hanchett
Barr Laboratories, Inc. (9th Cir. 2009) (“That [plaintiff] later moved to reopen her bankruptcy proceedings does not excuse her earlier failure to disclose; judicial estoppel ensures that debtors make a ‘full and honest disclosure’ of their assets in the original bankruptcy proceeding. [read post]
5 May 2009, 5:57 am
In Tallahassee, a suit against Barr Laboratories over a generic form of the hyperactivity drug Adderall was stalled for months waiting for the Wyeth decision, said Peter Kaufman, the lawyer for the mother of Kristina Flatt, 21, who died in 2005 of sudden cardiac arrhythmia. [read post]
10 Jul 2020, 1:36 pm by Bill Marler
See the following press releases for complete details on the recalled products: Fresh Express Hy-Vee Inc. [read post]
19 Aug 2020, 10:01 am by Bill Marler
Identification of this parasite in stool requires special laboratory tests that are not routinely done. [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas) Sprycel (Dasatinib)… [read post]
31 Dec 2009, 7:25 am
Court of Appeals in New York City, considering an action challenging a settlement agreement between drug maker Bayer AG and the generic defendant Barr Laboratories, Inc. [read post]
12 May 2015, 10:24 am by Jennifer Driscoll and Helen C. Eckert
Supreme Court had left up to future lower courts to develop.[1]  Cipro began more than a decade ago, stemming from a 1997 settlement of a patent infringement suit between Bayer AG and Bayer Corporation (the brand name patent holder) and Barr Laboratories, Inc. [read post]
26 Aug 2009, 9:20 am
Barr Labs., Inc., No. 2008-1282, 2009 U.S. [read post]
9 Nov 2010, 3:09 pm
On March 19, 2007, Barr Laboratories, Inc. and Barr Pharmaceuticals, Inc. [read post]
24 Jul 2014, 12:54 pm
District Judge Tanya Walton Pratt concluded that Defendants Teva Parenteral Medicines, Inc. of Irvine, California; APP Pharmaceuticals, LLC of Schaumburg, Illinois; Pliva Hrvatska D.O.O. of Zagreb, Croatia; Teva Pharmaceuticals USA Inc. of North Wales, Pennsylvania; and Barr Laboratories, Inc. of Montvale, New Jersey failed to prove invalidity of U.S. [read post]
10 Oct 2011, 10:00 am by Lucas A. Ferrara, Esq.
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
5 May 2010, 10:14 pm
Barr Labs., Inc., 437 F.3d 1181 (Fed. [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of… [read post]
3 Jun 2010, 5:35 am
– In re Ciprofloxacin Antitrust Litigation (PatLit) Circumvent PCV and Porcilis PCV vaccines – US: Wyeth files patent infringement suit against Intervet based on their manufacture of PCV vaccines (Patent Docs) Copegus (Ribavirin) – US: Ascio seeks declaratory judgment of unenforceability, invalidity and non-infringement of Three Rivers’ patent based on ANDA filing (Patent Docs) Entocort (Budesonide) – US: AstraZeneca settles Entocort patent suit with Teva, stipulates… [read post]